Skip to main content
logo
Chordia Therapeutics Inc. (TYO:190A)
Japan flag Japan · Delayed Price · Currency is JPY
79.00
+1.00 (1.28%)
Aug 6, 2026, 3:00 PM JST

Chordia Therapeutics Ratios and Metrics

Millions JPY. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Market Capitalization
6,02612,41851,534-
Market Cap Growth
-51.20%-75.90%--
Enterprise Value
3,5209,59648,276-
Last Close Price
78.00180.00780.00-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
PB Ratio
2.585.1012.38-
P/TBV Ratio
2.585.1012.39-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Net Debt / Equity Ratio
-1.07-1.05-1.04-1.07
Net Debt / EBITDA Ratio
1.741.432.41-22.00
Net Debt / FCF Ratio
-1.382.23-8.83
Quick Ratio
9.9210.439.1911.76
Current Ratio
10.1810.929.7811.98
Return on Equity (ROE)
-55.63%-54.13%-42.19%-
Return on Assets (ROA)
-32.30%-30.59%-23.60%-
Return on Capital Employed (ROCE)
-61.70%-73.40%-43.30%4.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Earnings Yield
-23.80%-14.38%-3.55%-
FCF Yield
-22.21%-14.84%-3.76%-
Buyback Yield / Dilution
-5.73%-16.82%-4.05%-